GFH-647

N/A

Report date: 2024/11/13 15:29:24
NME

Base Information

Drug NameGFH-647
Drug Alias NameGFH647GFH-647
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinases inhibitors
TargetsProtein kinases
Therapy Area/IndicationsLymphoma, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJinfang (Beijing) Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJinfang (Beijing) Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsLymphoma, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A